Correspondence
LOGO    

650 Town Center Drive, 20th Floor

Costa Mesa, California 92626-1925

Tel: +714.540.1235 Fax: +714.755.8290

www.lw.com

 

FIRM / AFFILIATE OFFICES

September 20, 2007

 

VIA EDGAR AND FACSIMILE

   

Barcelona

Brussels

Chicago

Frankfurt

Hamburg

Hong Kong

London

Los Angeles

Madrid

Milan

Moscow

Munich

 

New Jersey

New York

Northern Virginia

Orange County

Paris

San Diego

San Francisco

Shanghai

Silicon Valley

Singapore

Tokyo

Washington, D.C.

Securities and Exchange Commission

Division of Corporation Finance

100 First Street, N.E.

Washington, D.C. 20549

 

Attn:   Tim Buchmiller
  Senior Counsel
  Mail Stop 6010

 

Re:   Amgen Inc.
  Definitive Proxy Statement
  Filed March 22, 2007
  File Number: 000-12477

Dear Mr. Buchmiller:

On behalf of our client, Amgen Inc. (the “Company”), we confirm receipt of the comment letter to Mr. Kevin W. Sharer, the Company’s Chief Executive Officer, dated August 21, 2007, from the Staff of the Division of Corporation Finance of the Securities and Exchange Commission, concerning the above referenced filing. We are writing this letter to confirm that the Company anticipates submitting its response to the comment letter on or before October 15, 2007. The extension will enable the Company’s Compensation and Management Development Committee to review the draft responses to the comment letter at the Committee’s next regularly scheduled meeting to be held on October 2, 2007 and will enable management to reflect any views of the Committee in the comment letter response.

Please call me at 714-755-8261 if you have any questions regarding this letter.

 

Sincerely,

/s/ Regina M. Schlatter

Regina M. Schlatter

of LATHAM & WATKINS LLP